Synopses & Reviews
Extensively revised and updated, this second edition compares conventional and innovative drug delivery systems. The book covers significant ophthalmic advances and breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery. It examines procedures in pharmacokinetic/pharmacodynamic modeling for the determination of appropriate dosing regimens, covers new developments in animal modeling, and discusses current regulations governing patenting, commercial product release, and human testing. This in-depth reference lays the groundwork for overcoming constraints on the delivery of ophthalmic drugs.
Book News Annotation:
An in-depth reference which lays the groundwork for understanding
constraints on the delivery of ophthalmic drugs, and surveys the
delivery systems currently available or in various stages of research
and development. The 21 chapters cover topics such as anterior and
posterior segment microdialysis; ocular drug delivery; ophthalmic
formulation design; treatment of retino-choroidal and retinal
degenerative diseases; and the latest strategies in gene therapy,
ocular microdialysis, vitreous drug disposition modeling, and
receptor/transporter targeted drug delivery. For professionals or
advanced students in medicine, veterinary medicine, pharmaceuticals,
regulatory agencies, and related fields.
Annotation (c)2003 Book News, Inc., Portland, OR (booknews.com)
Synopsis:
The second edition of this text assembles significant ophthalmic advances and encompasses breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery.